Celebrating our 10th anniversary – Unlock our special offer today

A possible route to ‘reduced risk’ status for e-cigs in the EU?

At present it appears that article 13 of the EU Tobacco Products Directive (TPD) has been interpreted by all but one of the European Union’s 28 member states-Cyprus-as banning all claims of health and physical benefits relating to e-cigarette products.

While certain claims that a product is beneficial may be possible, they would require a medical licence. But there may be scope for a “reduced risk” classification, according to an ECigIntelligence report which draws parallels with the US Food and Drug Administration (FDA)’s modified risk tobacco product application (MRTPA).

Since e-cigarette products are officially acknowledged by health organisations in some European countries to contain fewer toxins than regular tobacco products such as cigarettes, it could be argued that they can help reduce the effects of smoking on public health.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    Promoting e-cigarettes as a reduced risk product would not affect their being categorised as a consumer/tobacco-related product, but the classification could change to that of a medicinal product if they are promoted as an aid to giving up smoking.

    This is important because the categorisation of the product defines it, not only in regard to making claims on packaging or in advertising but also in regard to regulations such as tax, notification systems, product requirements, labelling and packaging restrictions, and advertising. A pathway to a reduced-risk classification would not require a medical licence to be obtained.

    -ECigIntelligence staff

    Image: Gerd Altmann

    Author default picture


    This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization